Nicht lieferbar
Brain Norepinephrine - Ordway, Gregory A. / Schwartz, Michael A. / Frazer, Alan (eds.)
Schade – dieser Artikel ist leider ausverkauft. Sobald wir wissen, ob und wann der Artikel wieder verfügbar ist, informieren wir Sie an dieser Stelle.
  • Gebundenes Buch

Norepinephrine is a chemical neurotransmitter. Drugs that directly manipulate central nervous system (CNS) norepinephrine are being developed targeting noradrenergic neurons to deliver therapeutic effects. Noradrenergic drugs have been proven effective for depression and ADHD, and new disease indications are being identified. Recent discoveries about norepinephrine’s contribution to health, disease, and therapy make this synthesis of evidence, practice and research very timely. A team of experts provides the reader with a thorough understanding of the anatomy, physiology, molecular biology,…mehr

Andere Kunden interessierten sich auch für
Produktbeschreibung
Norepinephrine is a chemical neurotransmitter. Drugs that directly manipulate central nervous system (CNS) norepinephrine are being developed targeting noradrenergic neurons to deliver therapeutic effects. Noradrenergic drugs have been proven effective for depression and ADHD, and new disease indications are being identified. Recent discoveries about norepinephrine’s contribution to health, disease, and therapy make this synthesis of evidence, practice and research very timely. A team of experts provides the reader with a thorough understanding of the anatomy, physiology, molecular biology, pharmacology, and therapeutics of norepinephrine in the brain, including an extensive review of the role of norepinephrine in brain diseases. The book is divided into four sections: the basic biology of norepinephrine; the role that norepinephrine plays in behavior; evidence of norepinephrine’s role in CNS diseases, and the pharmacology and therapeutics of noradrenergic drugs in the treatment of psychiatric and neurological disorders.
Autorenporträt
Dr Ordway is Chair of the Department of Pharmacology at the James H. Quillen College of Medicine at East Tennessee State University.
Dr Schwartz is Clinical Professor of Psychiatry at the University of Hawaii. He is also Adjunct Professor of Philosophy and Adjunct Professor of Psychiatry at the University of Louisville in Louisville, Kentucky, and serves as Medical Director of the Irwin Foundation in Austin, Texas.
Dr Alan Frazer is Chair of the Department of Pharmacology at The University of Texas Health Science Center at San Antonio. He is also a Professor in the Department of Psychiatry at UTHSCSA and is an adjunct Professor in pharmacology departments at the College of Pharmacy of the University of Texas in Austin, and the School of Medicine of the University of Pennsylvania.